• Early signs for drug detection at Tour de France
    Drug detection on the Tour de France could be targeted at the best performers

Bioanalytical

Early signs for drug detection at Tour de France

Jul 05 2010

Early warning signs could decide who to test using liquid chromatography and mass spectrometry as part of a holistic approach to drug detection at the Tour de France.

With the race underway on July 3rd and due to last until July 25th, New Scientist notes developing theory in drug detection which compares race performance to the believed natural limitations of human endeavour.

"Work out the boundaries of human ability, based on what we know about physiology and its maximal capabilities," writes Jim Giles.

"If an athlete's performance lies outside this limit, they are highlighted as a potential drug-taker."

With 25 ascents into the Pyrenees and Alps on the schedule for the Tour de France, he adds that any particularly outstanding performances may be treated with suspicion.

The cynicism could aid drug detection efforts by allowing the usual mass spectrometry and liquid chromatography processes to be directed towards the competitors most likely to be using banned substances.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

AOCS Annual Meeting & Expo

Apr 28 2024 Montreal, Quebec, Canada

SETAC Europe

May 05 2024 Seville, Spain

ChemUK 2024

May 15 2024 Birmingham, UK

View all events